Treace Medical Concepts earnings were -$49.2M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest TMCI earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$17.4M, up 9.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TMCI reported annual earnings of -$55.7M, with 12.6% growth.
Treace Medical Concepts Earnings Reports & History FAQ
What were Treace Medical Concepts's earnings last quarter?
On TMCI's earnings call on Invalid Date, Treace Medical Concepts (NASDAQ: TMCI) reported Q2 2025 earnings per share (EPS) of -$0.28, up 17.65% year over year. Total TMCI earnings for the quarter were -$17.40 million. In the same quarter last year, Treace Medical Concepts's earnings per share (EPS) was -$0.34.
Is Treace Medical Concepts profitable or losing money?
As of the last Treace Medical Concepts earnings report, Treace Medical Concepts is currently losing money. Treace Medical Concepts's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$49.18 million, a 22.77% decrease year over year.
What was TMCI's earnings growth in the past year?
As of Treace Medical Concepts's earnings date in Invalid Date, Treace Medical Concepts's earnings has grown year over year. TMCI earnings in the past year totalled -$49.18 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.